Donald Trump

A federal judge ordered the Trump administration to secure funding for the CFPB amid a funding crisis, while President Trump is expected to name a Fed chair replacement in January ahead of Jerome Powell's term ending May 2026 — adding policy uncertainty for markets. The administration clinched an $8.6 billion Pentagon contract with Boeing for 25 F-15IA jets (option for 25 more by 2035), and Treasury actions include expanded HSA tax guidance, a planned $1,000–$2,000 refund boost for many filers, a new 'Trump account' child investment program, and pharma agreements to lower Medicaid drug costs. Fiscal pressures are highlighted by a reported US national debt of $38.386 trillion (12/30/25), and imminent Supreme Court tariff and Fed-chair rulings in January could have material macro and sectoral implications.

Analysis

Market structure: Defense (BA and peers) and consumer cyclicals are the clear near-term winners — Boeing’s $8.6B Israeli F‑15 win adds visible backlog and revenue visibility over 2026–2035, improving orderbook cash flow while higher deficits and fiscal stimulus point to upward pressure on nominal yields. Rate‑sensitive sectors (REITs like PGRE) and long‑duration growth are losers as anticipated fiscal expansion + tariff uncertainty push term premia wider and compress cap rates. Healthcare/pharma face two‑way pressure: drug price initiatives cap pricing power while HSA expansions boost elective-care demand.

Risk assessment: Key tail risks include a contentious Fed chair selection (Jan 2026) that could spike volatility, a Supreme Court tariff ruling reversing trade assumptions, or actions undermining Fed independence — each could move 10y yields ±50–100bp within weeks. Immediate catalysts: Jan Fed pick and Jan tariff decision; medium (3–9 months): 2026 tax‑refund flows; long (1–5 years): debt trajectory doubling risk driving structurally higher rates. Hidden dependencies include BA supply‑chain capacity, REIT refinancing cliffs, and implementation details of drug pricing deals.

Trade implications: Favor a tactical 6–18 month overweight to defense (BA) and consumer cyclicals ahead of refunds, funded by underweight REITs and long‑duration bonds. Use steepener (long 2s vs short 10s or short TLT) to express rising term premium; implement directional + options plays (LEAP calls on BA, puts on PGRE) to control risk. Position sizing should be small (1–3% per idea) with explicit stop‑losses tied to yield moves.

Contrarian angles: Consensus of a Trump‑driven 5% boom understates macro fragility — if 10y >4% or Fed pick is hawkish, growth multiples compress quickly; conversely, a Powell reappointment or rapid tariff easing could reflate long equities and flatten yields. BA upside may be capped by production/quality execution — treat contract wins as de‑risking, not free upside. Watch thresholds: 10y break of 3.5% and CFPB funding litigation resolution as near‑term decision triggers.

Key Decisions for Investors

• Establish a 1–2% notional long in BA (ticker: BA) via 9–15 month LEAP calls (near‑ATM strike) to capture defense backlog; trim or reassess on a 15–25% realized gain or if Boeing reports material production or cash‑flow slippage at next quarterly report.
• Establish a 1–2% short in PGRE (equity or 3–6 month put spread) to exploit rate sensitivity and bid‑withdrawal news; set stop‑loss at 10% adverse move and target 15–25% downside within 6–12 months, accelerating if 10y yield >3.5%.
• Implement a rates steepener: long 2y vs short 10y futures or short TLT sized to offset ~1–2% equity exposure for 3–6 months, targeting 30–50bp steepening; unwind if Fed pick signals dovish policy (e.g., Powell reappointment) or 10y yields fall below 3.0%.
• Build a 1–2% tactical long in consumer cyclicals (e.g., XLY) into 4Q–1Q 2026 tax‑refund window, funded by selling 4–6 week covered calls post‑refund announcements; reduce exposure if IRS refund estimates revise down by >20% or retail comps miss by >2%.